2005
DOI: 10.4049/jimmunol.174.11.6599
|View full text |Cite
|
Sign up to set email alerts
|

EBV and Systemic Lupus Erythematosus: A New Perspective

Abstract: We have proposed that EBV uses mature B cell biology to access memory B cells as a site of persistent infection. A central feature of this model is that EBV adapts its gene expression profile to the state of the B cell it resides in and that the level of infection is stable over time. This led us to question whether changes in the behavior or regulation of mature B cells would alter the state of EBV persistence. To investigate this, we studied the impact of systemic lupus erythematosus (SLE), a disease charact… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
178
0
4

Year Published

2009
2009
2018
2018

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 196 publications
(191 citation statements)
references
References 54 publications
7
178
0
4
Order By: Relevance
“…We determined the fractionated non-B-cell populations to be ∼97% pure, suggesting a maximum of ∼3% contaminating B cells. B-cell contamination therefore is unlikely to be the reason we detected BART miRNAs in the non-B-cell fractions, first because infection frequencies are very low, even in immune-suppressed patients with elevated EBV levels (29,30), and second because the viral genome was undetectable in the non-B cells. Overall, our data suggest that in asymptomatic patients BART miRNAs are expressed by latently infected circulating B cells but also are present in noninfected non-B cells, suggesting miRNA transfer in vivo.…”
Section: Ebv Bart Mirnas Are Present In Peripheral B Lymphocytes and mentioning
confidence: 97%
“…We determined the fractionated non-B-cell populations to be ∼97% pure, suggesting a maximum of ∼3% contaminating B cells. B-cell contamination therefore is unlikely to be the reason we detected BART miRNAs in the non-B-cell fractions, first because infection frequencies are very low, even in immune-suppressed patients with elevated EBV levels (29,30), and second because the viral genome was undetectable in the non-B cells. Overall, our data suggest that in asymptomatic patients BART miRNAs are expressed by latently infected circulating B cells but also are present in noninfected non-B cells, suggesting miRNA transfer in vivo.…”
Section: Ebv Bart Mirnas Are Present In Peripheral B Lymphocytes and mentioning
confidence: 97%
“…Although resting, these cells may retain the ability to release exosomes that have incorporated EBER1. However, latency III cells have been detected in circulation of individuals under immune suppression (44), and may represent an additional source of EBER1 + exosomes. Although chronic sensing of latent EBV may lead to disease in predisposed individuals, EBER1 recognition during early stages of EBV infection is possibly protective for the host, as at this time adaptive immune responses are not yet functional.…”
Section: Discussionmentioning
confidence: 99%
“…To evaluate whether EBER1 molecules are taken up by pDCs in vivo, we studied pDC-infiltrated skin lesions of lupus erythematosus (LE) patients that suffer from chronically elevated EBV loads (44). We examined paraffin sections of skin biopsies by immunofluorescent staining.…”
Section: Exosomes From Latent Ebv-infected Cells Target Primary Tonsimentioning
confidence: 99%
“…Although no single pathogen (except for a putative role for Epstein-Barr virus and parvovirus B19 (61,62)) has yet been associated with SLE immunopathogenesis, recent data seem to point towards the fact that chronic inflammation in SLE could arise from chronic immune system activation towards unknown infections (60).…”
Section: Infections Inflammation and Autoimmunity In Cvidmentioning
confidence: 99%